Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Product containing piperacillin and tazobactam (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Product containing piperacillin (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Product containing piperacillin and tazobactam (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Piperacillin with tazobactam |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin with tazobactam |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Product containing piperacillin and tazobactam (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam sodium (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Piperacillin sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
Product manufactured as parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tazobactam (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|